Jamie Oliver
Payments from drug & device makers
Across 146 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$516
- Amgen$331
- Dexcom, Inc.$174
- AstraZeneca$172
- Otsuka America Pharmaceutical, Inc.$160
- Novo Nordisk$139
- plus $1K from 34 others
What the payments were for
- Food & beverage$2,598100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $516 |
| Amgen | 19 | $331 |
| Dexcom, Inc. | 7 | $174 |
| AstraZeneca | 11 | $172 |
| Otsuka America Pharmaceutical, Inc. | 5 | $160 |
| Novo Nordisk | 8 | $139 |
| Lilly USA, LLC | 7 | $135 |
| Teva Pharmaceuticals USA, Inc. | 4 | $85 |
| Abbott | 4 | $69 |
| Merck | 4 | $59 |
| GSK | 4 | $58 |
| Novartis | 3 | $56 |
| Acadia Pharmaceuticals Inc | 3 | $52 |
| Lundbeck LLC | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $40 |
| Mylan Specialty L.p. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Sanofi-aventis U.S. LLC | 1 | $31 |
| Astellas Pharma US Inc | 2 | $31 |
| Johnson & Johnson | 2 | $29 |
| Vertex | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Organogenesis Inc. | 1 | $20 |
| Pfizer | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Viatris Specialty LLC | 1 | $16 |
| Bayer | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Sobi, Inc | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
| Daiichi Sankyo Inc. | 1 | $11 |
How this compares
$2,598 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 26 | $27,731 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $18,547 |
| EliquisApixaban | 32 | $17,943 |
| JardianceEmpagliflozin | 13 | $15,867 |
| FarxigaDapagliflozin Propanediol | 15 | $8,834 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $8,478 |
| JanuviaSitagliptin Phosphate | 14 | $7,861 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,980 |
| InvokanaCanagliflozin | 11 | $6,469 |
| Dexlansoprazole DrDexlansoprazole | 12 | $1,933 |
| Celecoxib | 26 | $1,307 |
| Bupropion XlBupropion Hcl | 43 | $1,252 |
| Ropinirole Hcl | 35 | $1,086 |
| Gabapentin | 74 | $1,047 |
| Duloxetine Hcl | 60 | $867 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $139 | $27,73126 claims |
| GSKTrelegy Ellipta | $58 | $18,54720 claims |
| PfizerEliquis | $18 | $17,94332 claims |
| Boehringer IngelheimJardiance | $13 | $15,86713 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $172 | $15,81426 claims |
| MerckJanuvia | $59 | $7,86114 claims |
| Johnson & JohnsonInvokana | $29 | $6,46911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.
Other family in Macon
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.